Mycophenolate mofetil for treatment of ongoing or chronic rejections after liver transplantation.
Pfitzmann
R
R
Department of Surgery, Charité, Virchow-Klinikum, Humboldt-University Berlin, Berlin, Germany.
Klupp
J
J
Langrehr
J M
JM
Neuhaus
R
R
Junge
G
G
Settmacher
U
U
Steinmüller
T
T
Neuhaus
P
P
D000284:Administration, Oral; D002908:Chronic Disease; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011184:Postoperative Period; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012189:Retrospective Studies
D016853:Muromonab-CD3; D011239:Prednisolone; D009173:Mycophenolic Acid